Sudip's Feed
Oct 24, 2014

Kering, BASF drag down European shares, Ebola eyed

LONDON, Oct 24 (Reuters) – Shares in luxury goods group
Kering and chemicals company BASF fell on
Friday after business updates, while new worries about the Ebola
virus weighed on European stock markets.

Kering fell 4.6 percent, making it the
worst-performing stock on the pan-European FTSEurofirst 300
index after sales fell at its Gucci brand.

Oct 24, 2014

European bank stocks outpace market before stress tests

LONDON, Oct 24 (Reuters) – European shares pared early
losses on Friday as investors bet the fallout for the banking
sector from stress test results due on Sunday should be
contained, and took a more measured view of New York’s first
case of Ebola.

The banking index rose 0.3 percent, boosted by hopes
that the weekend update on the sector’s financial health from
the European Central Bank should not reveal too many problems.

Oct 23, 2014

Slumps at Tesco and Unilever send UK’s FTSE lower

LONDON, Oct 23 (Reuters) – Britain’s top equity index fell
on Thursday, weighed down by a slump in the share prices of
supermarket operator Tesco and consumer goods group
Unilever.

The blue-chip FTSE 100 index, which has recovered
slightly after hitting 15-month lows last week, was down by 1.1
percent at 6,333.44 points in early session trading. The index
has fallen by around 6 percent since the start of 2014.

Oct 21, 2014

Stronger oil stocks and surge in Shire lift UK’s FTSE

LONDON, Oct 21 (Reuters) – Gains in big oil companies and
drugmaker Shire lifted Britain’s top equity index on
Tuesday, which extended a rebound after falling to 15-month lows
last week.

Advances of around 3 percent in both BP and Royal
Dutch Shell added the most points to the blue-chip FTSE
100 index, as stronger oil prices lifted energy stocks.

Oct 21, 2014

Gains in oil stocks and Shire lift UK’s FTSE

LONDON, Oct 21 (Reuters) – A rise in major oil stocks and
drugmaker Shire helped Britain’s top equity index extend
its rebound on Tuesday after falling to 15-month lows last week.

An advance of nearly 2 percent in both BP and Royal
Dutch Shell added the most points to the blue-chip FTSE
100 index, as the energy sector was buoyed by stronger
oil prices.

Oct 20, 2014

HSBC fall weighs on UK’s FTSE as rebound loses steam

LONDON, Oct 20 (Reuters) – Britain’s top equity index
slipped on Monday, as last week’s bounce off 15-month lows faded
and a dip in the shares of global bank HSBC pegged back
the market.

The blue-chip FTSE 100 index, which on Friday had
risen 1.9 percent, was down by 0.4 percent, or 23.27 points, at
6,287.02 points in early session trading.

Oct 17, 2014

Tullow comes out on top as UK’s FTSE rebounds off lows

LONDON, Oct 17 (Reuters) – Britain’s top equity index
rebounded from 15-month lows on Friday as concern eased over the
state of the U.S. economy, while Tullow Oil benefited
from a broker upgrade.

Rolls-Royce missed the rally, slumping 14.9 percent
after it warned that deteriorating economies in areas such as
Europe and China meant its profits would not rise next year as
it had forecast.

Oct 17, 2014

UK’s FTSE rises from 15-month low; Tullow on top

LONDON, Oct 17 (Reuters) – Britain’s top equity index
rebounded from 15-month lows on Friday as concern eased over the
state of the U.S. economy. Tullow Oil benefited from a
broker upgrade.

Rolls-Royce missed the rally, slumping 12.4 percent
after it warned that deteriorating economies in areas such as
Europe and China meant its profits would not rise next year as
it had forecast.

Oct 16, 2014

Fidelity’s Rossi says to buy U.S. stocks despite rout

LONDON, Oct 16 (Reuters) – The underlying strength of the
U.S. economy should enable U.S. stocks to recover from this
week’s sell-off, said Fidelity Worldwide Investments’ Dominic
Rossi, which he said had been made worse by hedge funds’ “poor”
trades.

Stocks in Europe and U.S. equity futures extended their
losses on Thursday, after Wednesday’s global market rout, mainly
caused by mounting concerns over the strength of the global
economy.

Oct 15, 2014

Hedge funds bleed as AbbVie reconsiders Shire bid

LONDON (Reuters) – Some of the world’s best known hedge funds lost hundreds of millions of dollars in the value of the stock they hold as Shire plunged after AbbVie’s decision to reconsider its $55 billion bid for the British healthcare group.

Data from Britain’s Financial Conduct Authority (FCA) regulatory body showed that no fund had a major “short” position of more than 0.5 percent, indicating that most hedge funds were confident of the deal’s success.